MGNX (STOCKS)
MacroGenics, Inc.
$3.980000
-0.040000 (-1.00%)
Prev close: $4.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Risser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $273.25M
- Employees
- 341
- P/E (TTM)
- -3.62
- P/B (TTM)
- 12.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $157.08M |
| Benefits Costs and Expenses | $224.78M |
| Costs And Expenses | $220.74M |
| Operating Expenses | $220.74M |
| Research and Development | $142.45M |
| Other Operating Expenses | $78.29M |
| Operating Income/Loss | -$63.66M |
| Income/Loss From Continuing Operations After Tax | -$70.36M |
| Income/Loss From Continuing Operations Before Tax | -$67.70M |
| Net Income/Loss | -$70.36M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$70.36M |
| Net Income/Loss Available To Common Stockholders, Basic | -$70.36M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.10 |
| Diluted Earnings Per Share | -$1.10 |
| Basic Average Shares | 189,861,639 |
| Diluted Average Shares | 189,911,997 |
| Assets | $217.87M |
| Current Assets | $182.52M |
| Inventory | $9.50M |
| Other Current Assets | $173.03M |
| Noncurrent Assets | $35.35M |
| Fixed Assets | $11.49M |
| Other Non-current Assets | $23.86M |
| Liabilities | $196.68M |
| Current Liabilities | $95.94M |
| Accounts Payable | $4.29M |
| Other Current Liabilities | $91.65M |
| Noncurrent Liabilities | $100.74M |
| Equity | $21.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.20M |
| Liabilities And Equity | $217.87M |
| Net Cash Flow From Operating Activities | -$69.96M |
| Net Cash Flow From Operating Activities, Continuing | -$69.96M |
| Net Cash Flow From Investing Activities | -$78.68M |
| Net Cash Flow From Investing Activities, Continuing | -$78.68M |
| Net Cash Flow From Financing Activities | $69.59M |
| Net Cash Flow From Financing Activities, Continuing | $69.59M |
| Net Cash Flow | -$79.05M |
| Net Cash Flow, Continuing | -$79.05M |
| Comprehensive Income/Loss | -$70.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$70.38M |
| Other Comprehensive Income/Loss | -$34.13M |